Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946
Sort by:

Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 40 pages

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 70 pages

Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 97 pages

Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 49 pages

Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Ta...

May 2022 92 pages

Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Thromboembolic Pulmonary Hypertension Drugs in Development...

May 2022 37 pages

Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Ta...

May 2022 44 pages

Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, R...

May 2022 39 pages

Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 120 pages

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Citrullinemia Type I (Arginosuccinate Synthetase De...

May 2022 35 pages

Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indicat...

May 2022 47 pages

Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Clostridium difficile Toxin A (toxA or...

May 2022 46 pages

Clostridium difficile Toxin B (toxB or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Clostridium difficile Toxin B (toxB or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Clostridium difficile Toxin B (toxB or...

May 2022 47 pages

CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 65 pages

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 63 pages

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Co...

May 2022 82 pages

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagul...

May 2022 59 pages

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagulation Factor...

May 2022 40 pages

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 144 pages

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Collagen Alpha 1(VII) Chain (...

May 2022 39 pages

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 62 pages

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Ta...

May 2022 40 pages

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Complement C1q Subcomponent Drugs in Development by Therapy A...

May 2022 36 pages

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 41 pages

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY C...

May 2022 52 pages

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, M...

May 2022 38 pages

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 47 pages

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 37 pages

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Intra-Abdominal Infections Drugs in Development by Stages, Ta...

May 2022 56 pages

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Skin And Skin Structure Infections (cSSSI) Dr...

May 2022 35 pages

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)...

May 2022 36 pages

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 42 pages

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 95 pages

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 56 pages

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 36 pages

Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 37 pages

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Coronary Artery Disease (CAD) (Ischemic Heart Disease) Dr...

May 2022 91 pages

Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by...

May 2022 36 pages

Corticobasal Degeneration (CBD-CBGD-Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Corticobasal Degeneration (CBD-CBGD-Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corticobasal Degeneration (CBD/CBGD/...

May 2022 36 pages

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 37 pages

CREB Binding Protein (CREBBP or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

CREB Binding Protein (CREBBP or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY CREB Binding Protein (CREBBP or EC 2.3.1.48)...

May 2022 44 pages

Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 38 pages

Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA...

May 2022 38 pages

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cruzipain (Major Cystein...

May 2022 35 pages

Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 39 pages

Cushings Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cushings Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cushing's Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pla...

May 2022 42 pages

Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 47 pages

Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 125 pages

Cyclic GMP-AMP Synthase (23-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cyclic GMP-AMP Synthase (23-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 38 pages

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cyclin Dependent Kinase (CDK or EC 2.7.11.2...

May 2022 184 pages

Filters

Search

Categories

209
1,199
32
238
214
187
155
140
64,297
1,312
1,311
2,468
184

Publishers

179
1
1,431
239
366
389
103
148
348
3
202
3
6
1,620
487
80
123
208
112
25
1,049
378
23
40
68
510
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,709
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
384
8
3
18
58
907
6
89
12
24
15
1,285
227
128
386
3
74
10
119
227
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
797
497
2
2
2
118
197
102
54
23
708
26
135
530
177
646
66,872

Price

—

Date

—

Pages

—

Offers

1
280
1
1